Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
Nature Communications|January 31, 2013
A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degenerationSatoshi Nojima, Toshihiko Toyofuku, Hiroyuki Kamao, et al.Nature Communications|October 13, 2016
Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signalsTetsuya Kimura, Shigeyuki Nada, Noriko Takegahara, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2015
mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T CellsDaisuke Ito, Satoshi Nojima, Masayuki Nishide, et al.Molecules (Basel, Switzerland)|May 25, 2019
Functional Fragments of AIMP1-Derived Peptide (AdP) and Optimized Hydrosol for Their Topical Deposition by Box-Behnken DesignJeong-Jun Lee, Young-Min Han, Tae-Wan Kwon, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2018
Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EBYoshitomo Hayama, Tetsuya Kimura, Yoshito Takeda, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 4, 2017
Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive FunctionTakashi Hosokawa, Tetsuya Kimura, Shigeyuki Nada, et al.Autophagy|January 30, 2024
ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cellsMinsoo Koh, Hyesol Lim, Hao Jin, et al.Annals of the Rheumatic Diseases|April 19, 2017
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitisMasayuki Nishide, Satoshi Nojima, Daisuke Ito, et al.Health Technology Assessment (Winchester, England)|August 21, 2015
Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trialVasiliki Orgeta, Phuong Leung, Lauren Yates, et al.Nature Communications|February 8, 2023
TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integritySujin Kang, Jaekyung Kim, Areum Park, et al.Pageof 13